Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr 12;6(4):294-7.
Print 2013.

Alterations in prothrombin time and activated partial thromboplastin time in patients with acute myocardial infarction

Haseeb A Khan  1 , Abdullah S Alhomida, Tamader Y Al Rammah, Samia H Sobki, Mohammad S Ola, Adnan A Khan
Affiliations

Alterations in prothrombin time and activated partial thromboplastin time in patients with acute myocardial infarction

Haseeb A Khan et al. Int J Clin Exp Med. .

Abstract

Prothrombin time (PT) and activated partial thromboplastin time (aPTT) respectively measures the extrinsic and intrinsic pathways of coagulation and are used to determine the bleeding or clotting tendency of blood. We compared PT and aPTT levels in acute myocardial infarction (AMI) patients and normal subjects. There were significant increases in PT levels in patients with STEMI (15.98 ± 0.96 s), NSTEMI (16.03 ± 0.97 s) and chest pain (15.02 ± 0.54 s) as compared to control group (8.86 ± 0.08 s). The level of aPTT in control subjects was 31.35 ± 0.48 s. Patients with STEMI (40.79 ± 1.83 s), NSTEMI (41.33 ± 2.06) and chest pain (37.84 ± 1.66 s) showed significantly higher levels of aPTT. There was a significant correlation between PT and aPTT levels. Both PT and aPTT were significantly correlated with age however there was no correlation between these coagulation markers and gender or body mass index. In conclusion, both PT and aPTT are significantly increased in AMI patients on anticoagulation therapy. The elevations in PT values were more than 2.5-fold greater than aPTT suggesting a high potential of PT for predicting blood clotting tendency in patients receiving anticoagulation therapy.

Keywords: Acute myocardial infarction; PT; aPTT; biomarker.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Blood coagulation markers in different groups. *P<0.01 and *P<0.001 versus control group using Dunnett’s multiple comparison test.
Figure 2
Figure 2
Correlation between PT and aPTT (correlation coefficient= 0.620, P<0.001, Pearson’s test).
See this image and copyright information in PMC

References

    1. Kostis JB, Baughman DJ, Kuo PT. Association of recurrent myocardial infarction with hemostatic factors: a prospective study. Chest. 1982;81:571–575. - PubMed
    1. Li YH, Teng JK, Tsai WC, Tsai LM, Lin LJ, Guo HR, Chen JH. Prognostic significance of elevated hemostatic markers in patients with acute myocardial infarction. J Am Coll Cardiol. 1999;33:1543–1548. - PubMed
    1. Galvani M, Ferrini D, Ottani F, Eisenberg PR. Early risk stratification of unstable angina/non-Q myocardial infarction: biochemical markers of coronary thrombosis. Int J Cardiol. 1999;68(Suppl 1):S55–S61. - PubMed
    1. Derhaschnig U, Laggner AN, Röggla M, Hirschl MM, Kapiotis S, Marsik C, Jilma B. Evaluation of coagulation markers for early diagnosis of acute coronary syndromes in the emergency room. Clin Chem. 2002;48:1924–1930. - PubMed
    1. Saigo M, Waters DD, Abe S, Biro S, Minagoe S, Maruyama I, Tei C. Soluble fibrin, C-reactive protein, fibrinogen, factor VII, antithrombin, proteins C and S, tissue factor, D-dimer, and prothrombin fragment 1 + 2 in men with acute myocardial infarction ≤ 45 years of age. Am J Cardiol. 2004;94:1410–1413. - PubMed

LinkOut - more resources